The dermatologist-founded challenger brand backed by one of the largest skincare communities in the world is taking on generic formulas, over-hyped ingredients, and big beauty's complex routines; with ...

(via Sabine Hossenfelder) It’s a new year, and according to a new paper, physics is headed into a new era. Over the past few years, the field of physics has seen a major shift in research priorities – ...

In October 2022, astronomers detected the brightest gamma-ray burst ever recorded, caused by the collapse of a massive star 2 billion light years away. Despite the immense distance, the radiation was ...

It's never too late to solve a cold case. A new paper from Syracuse University researchers proposes an explanation for both a mysterious stellar object discovered in the year 2013 and an astronomical ...

SpaceX said it experienced an anomaly with one if its Starlink satellites that was likely caused by a small explosion. "The anomaly led to venting of the propulsion tank, a rapid decay in semi-major ...

While the 21st century has been bumpy, it has also ushered in monumental scientific and technological breakthroughs that have changed our world for the better. Advances in medicine have allowed for ...

The era of explosive Bitcoin (CRYPTO: BTC) rallies is fading, with stablecoins and DeFi set to drive crypto's real growth next year, according to Galaxy Research’s 2026 outlook. In the report ...

Exceptionally preserved fossils from the Ediacaran period challenge what scientists thought was possible in sandstone. In the fossil record, creatures without hard shells or skeletons, such as ...

After spending last year overhauling their artificial intelligence (AI) business, Korea's two internet giants, Naver and Kakao, are now accelerating their push toward redefining their flagship search ...

Bitcoin's price chart looks super calm right now, according to Bollinger Bands, a key volatility gauge, hinting at a massive swing ahead. BTC has traded in a tight range between $85,000 and $90,000 ...

Something remarkable is happening in Chinese biotech, and it’s happening fast. The country’s drug developers are learning to run — really run — through clinical trials and regulatory approvals. In an ...